GlassScriptPhysician profile
Wilson P Daugherty
NPI 1023094950
$6,129.17
in general payments reported to CMS, 2019-2025
7 companies · $537 in 2025
The $537 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,072 · 2020: $722 · 2021: $1,045 · 2022: $538 · 2023: $190 · 2024: $2,026 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,446 · Food and Beverage: $1,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,446.01 |
| Food and Beverage | $1,306.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,171.40 | 2021-2025 | Pipeline, Mazor X System, Stealthstation S8 Platform |
| Depuy Synthes Sales INC. | $1,255.04 | 2019-2022 | |
| Medtronic USA, INC. | $745.43 | 2019-2020 | |
| Brainlab, INC. | $546.26 | 2019-2022 | |
| Stryker Corporation | $234.57 | 2020-2021 | |
| W. L. Gore & Associates, INC. | $122.72 | 2023 | Gore Excluder Aaa Endoprosthesis |
| Sanara Medtech INC. | $53.75 | 2025 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wilson Daugherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.